For Medical Professionals

Provider Education Resources for ME/CFS

• Clinical Care Guide
  Bateman Horne Center Diagnostic and management guidance for ME/CFS, Long COVID, and related infection-associated chronic conditions (IACCs). Free downloadable clinical consensus materials.

• CME / Project ECHO Series
  Bateman Horne Center, Open Medicine Foundation, University of Utah Long COVID & Post-Viral Syndrome ECHO series with case-based mentoring and expert-led discussions. Accredited CME available.

• Accredited CME Courses
  Bateman Horne Center, Medscape (CDC partner), MEAction/Mayo Clinic  Includes CDC-collaborated Medscape courses and Essentials of Diagnosis and Management article

• CME/CNE Educational Event
  Johns Hopkins (JHU) / NIOSH ERC “ME/CFS: An Overview of Symptoms and Current Research.”.

• CME for Rehabilitation Professionals
  Workwell Foundation / MedBridge
  Two-part accredited course focusing on ME/CFS identification, exercise impairment, and pacing for physical, occupational, and speech therapists.

• Specialty CPD/CME (Mental Health)
  Psych Scene (The Academy) 10-hour masterclass accredited by RACGP (Australia), covering neuropsychiatry and psychoneuroimmunology of ME/CFS and Long COVID.

• CME Courses (New York State)
  NY State DOH Clinical Education Initiative  “Post-viral syndrome and myalgic encephalomyelitis: what every clinician needs to know.” Offers 1.0 AMA PRA Category 1 Credits™.

• Educational Modules
  MEAction, Bateman Horne Center, U.S. ME/CFS Clinician Coalition, Action for ME (UK) Free clinician education modules. Action for ME offers CPD-accredited training based on 2021 NICE guidelines; others provide non-credit videos.

• Academic CME / Grand Rounds
  Harvard, Stanford, USC (Occasional) Live or recorded sessions on ME/CFS, Long COVID, and autonomic dysfunction. Not part of a sustained CME curriculum.

ME/CFS San Diego Fliers:

• MECFS 2025 Black and White Flyer for Medical Professionals  ME/CFS at a Glance: Facts & Diagnosis for Healthcare workers (or anyone) with reputable links and IOM diagnosis chart. (B&W PDF)

• MECFS 2025 Full Color Flyer for Medical Professionals ME/CFS at a Glance: Facts & Diagnosis for Healthcare workers (or anyone) with reputable links and IOM diagnosis chart. (Full Color PDF)

For Physical Therapists: 

• Myalgic Encephalomyelitis or Chronic Fatigue Syndrome - Physiopedia 

• https://batemanhornecenter.org/providers/mecfs/diagnosing-managing/rehab-professionals/ 

• https://www.physiosforme.com/onesheetprintout 

• Post-COVID Fatigue, Exercise Intolerance Signal ME/CFS "The major finding is that ME/CFS is indeed part of the spectrum of the post-COVID syndrome and very similar to the ME/CFS we know after other infectious triggers," senior author Carmen Scheibenbogen, MD, acting director of the Institute for Medical Immunology at the Charité University Medicine Campus Virchow-Klinikum, Berlin, Germany

From the July 2021 Medical Board of California News

"Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID:

What Every Physician Needs to Know

By The Myalgic Encephalomyelitis Action Network (MEAction), with special contribution from Jennifer Curtin, MD, Center for Complex Diseases, Mountain View, CA

Body: MEAction urges physicians to consider myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in the differential diagnosis of long COVID patients. For those exhibiting post-exertional malaise, graded exercise programs may be harmful. This article provides information on ME/CFS and COVID long-haulers showing symptoms of ME/CFS.

Post-Acute Sequelae of SARS-CoV-2 Infection and ME/CFS

Many COVID-19 survivors are experiencing significant symptoms persisting months beyond resolution of the acute viral infection. These symptoms involve a wide range of organ systems: cardiovascular, pulmonary, neurological, renal, gastrointestinal, immune, and more. To address this emerging issue, the National Institutes of Health (NIH) held the Post-Acute Sequelae of COVID-19 workshop and was awarded $1.15 billion to study what is now referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), or simply long COVID.

A recent survey of nearly 4,000 self-described COVID long-haulers indicates that 78 percent are experiencing persistent fatigue, 72 percent are experiencing post-exertional malaise, and 55 percent are experiencing cognitive dysfunction six months or longer after acute infection. These symptoms are the three most common among surveyed long-haulers, and all three are primary diagnostic criteria for ME/CFS.

What is ME/CFS?

Referred to by the Centers of Disease Control and Prevention (CDC) as America’s Hidden Health Crisis, ME/CFS is a chronic, systemic disease that is associated with neurological, immunological, and energy metabolism impairment. The National Academy of Medicine published a report in 2015 where a panel of experts reviewed over 9,000 studies and concluded that ME/CFS is a multi-system disease often preceded by an immune challenge, most frequently an infection. The hallmark symptom of ME/CFS is post-exertional malaise: a significant worsening of fatigue and associated symptoms after physical or cognitive exertion. Other symptoms include a substantial impairment in function, profound exhaustion, unrefreshing sleep, cognitive impairment, orthostatic intolerance, widespread pain, flu-like symptoms and sensory hypersensitivities.

Pre-COVID-19 data indicates ME/CFS affects an estimated 1.5 million Americans, of whom, 75 percent are so severely affected they are unable to work full time, and 25 percent are homebound or bedridden. The direct medical cost and indirect cost to society of ME/CFS in the U.S., based on study data published in 2008 and recently updated to present day population and economics, is $36-51 billion annually.

COVID-19 Might Lead to a Tripling of ME/CFS Cases

Rates of development of ME/CFS after infection with SARS, MERS, West Nile virus, or EBV range from 5 percent to 27 percent. A recent paper by the US ME/CFS Clinician Coalition, an organization representing the collective clinical expertise on ME/CFS in the U.S., estimates that 10 percent of those stricken with COVID-19 will develop ME/CFS. With the number of COVID-19 cases in the U.S. exceeding 30 million, 10 percent developing ME/CFS would result in a tripling of the existing ME/CFS prevalence in the U.S. alone. The numbers are significant when applied to the number of COVID-19 survivors globally.

Standard Graded Exercise Programs can be Harmful for ME/CFS Patients

Evidence shows COVID long-haulers with ME/CFS symptoms - specifically, post-exertional malaise - should consider against enrolling in graded exercise therapies, which may be harmful to people with ME/CFS. MEAction encourages long-haulers to pace their activities and build in regular rest periods.

There is extensive metabolic and molecular evidence that people with ME/CFS experience physiological abnormalities in their response to exercise. Results from two-day cardiopulmonary exercise tests (CPET) and a multi-center invasive CPET study provide additional evidence of an abnormal response to exercise in patients with ME/CFS and confirm that the symptoms are not the result of deconditioning, but instead suggestive of maldistributed blood flow and reduced tissue oxygen extraction during upright exertion, possibly related to the small fiber neuropathy found in nearly 30 percent of study participants. Exertion beyond a patient’s tolerance can lead to post-exertional malaise and a long-term worsening of symptoms. A recent large-scale survey found that 80 percent of people with ME/CFS found no benefit or significantly worsened with upright graded exercise regimens.

Treatment to Consider for Long-Haulers who Might have ME/CFS

The U.S. ME/CFS Clinician Coalition has recently issued a letter titled Post-COVID ‘Long-Haulers’ and ME/CFS emphasizing the importance of considering ME/CFS in the differential diagnosis of long COVID patients. The Coalition provides information to help diagnose ME/CFS and its common comorbidities, and manage the condition in different age groups."

Copied from https://www.mbc.ca.gov/News/Newsletter/2021-July.aspx ,Volume 157, July 2021 Medical Board of California News